Literature DB >> 31552604

Authors' Reply to Ravi Jandhyala's Comment on "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments".

Patricia McGettigan1, Carla Alonso Olmo2, Kelly Plueschke2, Mireia Castillon2, Daniel Zondag2, Priya Bahri2, Xavier Kurz2, Peter G M Mol3,4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31552604     DOI： 10.1007/s40264-019-00863-w

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  8 in total

1.  The randomized registry trial--the next disruptive technology in clinical research?

Authors:  Michael S Lauer; Ralph B D'Agostino
Journal:  N Engl J Med       Date:  2013-08-31       Impact factor: 91.245

2.  Qualitative synthesis and systematic review in health professions education.

Authors:  Margaret Bearman; Phillip Dawson
Journal:  Med Educ       Date:  2013-03       Impact factor: 6.251

3.  Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013.

Authors:  Jacoline C Bouvy; Kevin Blake; Jim Slattery; Marie L De Bruin; Peter Arlett; Xavier Kurz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-03-26       Impact factor: 2.890

Review 4.  Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research?

Authors:  Guowei Li; Tolulope T Sajobi; Bijoy K Menon; Lawrence Korngut; Mark Lowerison; Matthew James; Stephen B Wilton; Tyler Williamson; Stephanie Gill; Lauren L Drogos; Eric E Smith; Sunita Vohra; Michael D Hill; Lehana Thabane
Journal:  J Clin Epidemiol       Date:  2016-08-20       Impact factor: 6.437

5.  Comment on: "Patient Registries: An Underused Resource for Medicines Evaluation: Operational Proposals for Increasing the Use of Patient Registries in Regulatory Assessments".

Authors:  Ravi Jandhyala
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

6.  Imposed registries within the European postmarketing surveillance system: Extended analysis and lessons learned for regulators.

Authors:  Alexandra Pacurariu; Kelly Plueschke; Carla Alonso Olmo; Xavier Kurz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-05-11       Impact factor: 2.890

7.  Barriers and Opportunities for Use of Patient Registries in Medicines Regulation.

Authors:  Carla Alonso Olmo; Patricia McGettigan; Xavier Kurz
Journal:  Clin Pharmacol Ther       Date:  2019-04-10       Impact factor: 6.875

8.  Patient Registries: An Underused Resource for Medicines Evaluation : Operational proposals for increasing the use of patient registries in regulatory assessments.

Authors:  Patricia McGettigan; Carla Alonso Olmo; Kelly Plueschke; Mireia Castillon; Daniel Nogueras Zondag; Priya Bahri; Xavier Kurz; Peter G M Mol
Journal:  Drug Saf       Date:  2019-11       Impact factor: 5.606
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.